HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Potential therapeutic gene for the treatment of ischemic disease: Ad2/hypoxia-inducible factor-1alpha (HIF-1)/VP16 enhances B-type natriuretic peptide gene expression via a HIF-1-responsive element.

Abstract
In this issue of Molecular Pharmacology, Luo et al. (p. 1953) present a study employing a HIF-1alpha/VP16 chimera to investigate the mechanism by which this constitutively active transcription factor activates expression of brain natriuretic peptide (BNP). The results define a functional hypoxia responsive element (HRE) in the promoter of the human BNP gene and demonstrate that this HRE is necessary for HIF-1alpha/VP16-induced gene expression in human cardiomyocytes grown under normoxic conditions. Luo et al. also show that a consensus E-box DNA binding sequence is necessary for appropriate BNP regulation. Because HIF-1 is known to elicit protective and beneficial gene expression programs in many scenarios and because BNP is known to be cardioprotective, this study provides support for the therapeutic use of the chimeric HIF-1alpha/VP16 protein in coronary heart disease. However, because HIF-1alpha is a key regulatory molecule that acts upon a large number of downstream gene networks, there remains a need for further investigation. Particularly useful would be comprehensive gene expression profiling coupled with functional analysis of HIF-1alpha/VP16-regulated genes. The results of such studies will elucidate the mechanism of beneficial effects and address concerns regarding potential adverse effects of activating specific HIF-1alpha/VP16-dependent gene programs.
AuthorsMichael E Wilhide, W Keith Jones
JournalMolecular pharmacology (Mol Pharmacol) Vol. 69 Issue 6 Pg. 1773-8 (Jun 2006) ISSN: 0026-895X [Print] United States
PMID16567545 (Publication Type: Journal Article, Comment)
Chemical References
  • Ad2-HIF-1-VP16 protein
  • Hypoxia-Inducible Factor 1
  • Recombinant Fusion Proteins
  • Natriuretic Peptide, Brain
Topics
  • Coronary Disease (therapy)
  • Genetic Therapy
  • Humans
  • Hypoxia (genetics, therapy)
  • Hypoxia-Inducible Factor 1 (metabolism)
  • Myocytes, Cardiac (metabolism)
  • Natriuretic Peptide, Brain (genetics)
  • Recombinant Fusion Proteins (genetics, metabolism)
  • Response Elements (genetics)
  • Transcriptional Activation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: